Market Research Insights

  San Francisco, 13 June 2024:  The Report  Clinical Trials Market  Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, Indication By Study Design, By Sponsors, By Service Type, By Region and Segment Forecasts, 2024 - 2030 The market growth spiked in 2020 owing to the COVID-19 pandemic. This growth pattern was witnessed by both virtual clinical trials and traditional ones. Several companies invested heavily in novel drug development to minimize COVID-19 patient burden. One such example being, in 2020, Synairgen plc and Parexel collaborated on a Phase III study of Interferon-beta (IFN-beta) treatment for COVID-19. Furthermore, rapid technological evolution, rising prevalence of chronic diseases, globalization of clinical trials, penetration of personalized medicine and a rise in demand for CROs for conducting research activities is expected to positively impact the market growth. The growing preva...

San Francisco, 16 July 2019:   The Report   Clinical Trials Market   Size, Share & Trends Analysis Report By Phase (I/II/III/IV), By Study Design (Interventional, Expanded Access), By Indication (Oncology, Diabetes, Obesity), And Segment Forecasts, 2019 – 2026 The global clinical trials market size is expected to reach USD 68.9 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% during the forecast period. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and rising demand for CROs to conduct clinical trials. Globalization has led to increase in investment in new product development in emerging countries thereby, positively impacting the market. The availability of the vast array of services from drug discovery to post-marketing surveillance has further simplified the...